Davina Gale,
Head of Molecular Diagnostics, Co-Founder,
Inivata
Davina Gale is co-founder and Head of Molecular Diagnostics at Inivata, a clinical cancer genomics company developing clinical applications of circulating tumour DNA (ctDNA) to improve testing and treatment for oncologists and their patients. Prior to this, Davina worked for 20 years in the pharmaceutical industry, gaining expertise in the identification and validation of novel genomic disease biomarkers, including incorporating their use in Phase I/IIa clinical trials. She subsequently joined Nitzan Rosenfeld’s group as Lab Manager of the Molecular and Computational Diagnostics group at the Cancer Research UK Cambridge Institute, University of Cambridge. She is part of the team that pioneered novel next generation sequencing approaches for analysis of ctDNA, including development of the TAm-Seq™ technology, which has been licensed to Inivata for the analysis of ctDNA as a non-invasive ‘liquid’ biopsy for personalised cancer therapy.
|
|
|
Add to Calendar ▼2015-03-23 12:00:002015-03-23 13:00:00Europe/LondonNoninvasive Cancer Genomics and Exploring Potential Clinical Applications of Circulating Tumor DNASELECTBIOenquiries@selectbiosciences.com
